Jenburkt Pharmaceuticals Ltd

BSE:524731

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JENBURPH's stock price target?

Price Target

520 INR

According to Wall Street analysts, the average 1-year price target for JENBURPH is 520 INR .

What is Jenburkt Pharmaceuticals Ltd's Revenue forecast?

Projected CAGR

-5%

For the last 8 years the compound annual growth rate for Jenburkt Pharmaceuticals Ltd's revenue is 6%. The projected CAGR for the next 7 years is -5%.

What is Jenburkt Pharmaceuticals Ltd's Operating Income forecast?

Projected CAGR

-4%

For the last 8 years the compound annual growth rate for Jenburkt Pharmaceuticals Ltd's operating income is 11%. The projected CAGR for the next 7 years is -4%.

What is Jenburkt Pharmaceuticals Ltd's Net Income forecast?

Projected CAGR

-9%

For the last 8 years the compound annual growth rate for Jenburkt Pharmaceuticals Ltd's net income is 12%. The projected CAGR for the next 7 years is -9%.